Your browser doesn't support javascript.
loading
Adenosine A2A agonists: a potential new type of atypical antipsychotic.
Rimondini, R; Ferré, S; Ogren, S O; Fuxe, K.
Afiliação
  • Rimondini R; Department of Neuroscience, Karolinska Institute, Stockholm, Sweden.
Neuropsychopharmacology ; 17(2): 82-91, 1997 Aug.
Article em En | MEDLINE | ID: mdl-9252983
ABSTRACT
The systemic intraperitoneal (i.p.) administration of the adenosine A2A agonist CGS 21680 was found to dose-dependently antagonize spontaneous and amphetamine-induced (1 mg/kg i.p.) motor activity with similar ED50 values (about 0.2 mg/kg). The ratios between the ED50 values for induction of catalepsy and for antagonizing amphetamine-induced motor activity for CGS 21680, haloperidol, and clozapine were 12, 2, and > 30, respectively. Furthermore, CGS 21680 was comparably much stronger than haloperidol or clozapine at antagonizing the motor activity induced by phencyclidine (2 mg/kg subcutaneously) than motor activity induced by amphetamine (1 mg/kg i.p.). In conclusion, the present results show a clear "atypical" antipsychotic profile of the adenosine A2A agonist CGS 21680 in animal models.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Fenetilaminas / Antipsicóticos / Adenosina / Receptores Purinérgicos P1 / Anti-Hipertensivos Limite: Animals Idioma: En Ano de publicação: 1997 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Fenetilaminas / Antipsicóticos / Adenosina / Receptores Purinérgicos P1 / Anti-Hipertensivos Limite: Animals Idioma: En Ano de publicação: 1997 Tipo de documento: Article